Sign inJoin waitlistJoin the waitlist

Carlos Milla

Professor of Pediatrics, Pulmonary Division, CF Center Director, Pediatrics. · Stanford Health Care

Credentials: · · ·

History

Pulmonary Division · Stanford Health Care
Present
Pediatrics. · Stanford Health Care
Present
Stanford Health Care
Present

Pediatric Pulmonology
1989–1992
Pediatrics
1986–1989
Doctor of Medicine
1982–1986

Research

Autonomous sweat extraction and analysis applied to cystic fibrosis and glucose monitoring using a fully integrated wearable platform
Proceedings of the National Academy of Sciences of the United States of America · 2017 · 432 citations
Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline
Systematic review or meta-analysis · American Journal of Respiratory and Critical Care Medicine · 2018 · 393 citations
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review
Review · Pediatric Pulmonology · 2016 · 331 citations

Margaret Rosenfeld
26 papers
Stephanie Davis
24 papers
Thomas Ferkol
23 papers
EB
Elizabeth Burgener
22 papers · 1 as a fellow
Paul Bollyky
22 papers
Margaret Leigh
21 papers
Michael Knowles
21 papers
Scott Sagel
21 papers
AS
Adam Shapiro
16 papers
JS
Jacquelyn Spano
16 papers
Kenneth Olivier
12 papers
David Cornfield
11 papers

Grants

An Autonomous, Non-Invasive, and Bioanalytics-Enabled Wearable Platform for Precision Nutrition and Personalized Medicine
National Institute of Diabetes and Digestive and Kidney Diseases · R33
PI · $1.9M · University of California Los Angeles
2021–2026
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis Lung Infections
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · Stanford University
2019–2024
An Autonomous, Non-Invasive, and Bioanalytics-Enabled Wearable Platform for Precision Nutrition and Personalized Medicine
National Institute of Diabetes and Digestive and Kidney Diseases · R21
PI · $406.7K · University of California Los Angeles
2021–2023
Elafin Therapy for Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · P01
Project lead · $2.9M · Stanford University
2017

Clinical trials

Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With CF
Principal investigator · Completed
Stanford University
2013–2014
Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa
Principal investigator · Completed · Phase 1, Phase 2
Humanigen, Inc.
2008–2009
A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
Principal investigator · Terminated · Phase 1
University of Minnesota
2006